Clinical trial
DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated…
NCT00224081 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00224081 |
|---|---|
| Title | DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) |
| Official title | Dialysis Patients' Response to IV Iron With Elevated Ferritin |
| Acronym | DRIVE |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Iron-Deficiency, Kidney Failure, Chronic, Hemodialysis |
| Intervention type | Drug |
| Interventions | Sodium ferric gluconate |
| Enrollment | 134 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 10, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: